Synairgen Share Discussion Threads

[vitec] 26/5/2020 08:50

There is a persistent 10k seller

[lauders] 26/5/2020 08:46

Perhaps they missed the outlook:

Outlook

During the calendar year 2019 we made good progress in the trial of our wholly-owned asset SNG001 in COPD. The emergence of SARS-CoV-2 has caused us to pause the COPD trial and to divert our expertise and investment to addressing the more pressing COVID-19 pandemic. Knowing that a broad spectrum antiviral agent delivered directly to the lungs may prevent the development of lower respiratory tract illness or accelerate the recovery of patients already hospitalised, we have raised additional funding of £14 million, which has enabled us to successfully initiate a trial of approximately 220 patients with COVID-19, some 100 of whom are in the hospital environment with severe respiratory symptoms, with a further 120 patients who will be dosed in the home environment upon early signs of COVID-19. Our staff and our key suppliers in both the UK and overseas have been able to continue working through lockdown. Data from the hospital trial will read out during the summer, and, if positive, the Company will work closely with regulators to determine an expeditious route to securing approval for SNG001, a treatment we believe could play an important role in addressing the current COVID-19 crisis and similar viruses in the future. In parallel, the Company is now working with manufacturers to scale up for potential demand for SNG001. The outlook for the business is positive and we look forward to updating the market on further progress in due course.

My bold. I may just be the "ifs", "coulds" etc....

[nojjer41] 26/5/2020 08:46

That sounds very wise! I’ve been tempted into yet another top up, but I’m walking away from the screen now for a while before the wife decides she’s going to kill me ;-)
GLA

[vitec] 26/5/2020 08:46

Just shows the fickle nature of humans. The sun is shining, a relaxation in lockdown restrictions and people think the virus has gone away. There is a desperate need for a treatment. It seems SNG can fill that space. I have purchased a few more today but I suspect that it will be a few weeks more before we see any tangible move in the share price as results are not due to July. Why take a position now will probably be what some investors are thinking.

[eeza] 26/5/2020 08:41

Market doesn't seem to have read the RNS' yet.

[adman50] 26/5/2020 08:13

Albeit somewhat annoying some successful sites like Leicester closed early whom could have filled otherwise...

[malctim70] 26/5/2020 08:12

hxxps://www.thesun.co.uk/news/11707597/brit-scientists-develop-coronavirus-inhaler-fight-disease-symptoms/

[makendon] 26/5/2020 08:11

That’s it, I’m not watching this for the rest of today... off for a bacon sarnie and a latte!

[adman50] 26/5/2020 08:09

Strap yourselves in for July results people. 2 more patients to enroll which ain't bad considering the drop in reported infections.

[makendon] 26/5/2020 08:07

So..... sell on good news? WTF....

Or is it the wait till July investors don’t like?

[ramridge] 26/5/2020 08:02

Ok, OK, stop throwing stones!!! I missed it , alright?

[eeza] 26/5/2020 08:01

CEO was asked about cash levels in 1 of the interviews and said did not need to raise more. Only 3 staff & no dedicated offices.

[74tom] 26/5/2020 07:57

Ramridge, are you living on the moon? They raised £14m in March at 35p! No capital required any time soon...

[dave444] 26/5/2020 07:56

They have already just raised 14m!Do you know anything about this company?

[crookie3634] 26/5/2020 07:56

Ramridge the company has already raised capital and part of that was to strengthen the balance sheet. This won’t be in the results today but will be see them through this year and I expect they should see some cash should the results be successful. I think they have planned for this so no need to raise capital in the short or medium term imo

[coxypete] 26/5/2020 07:55

Ramridge placement was done in March 2020 - so funding already taken care of. https://www.google.co.uk/amp/s/www.proactiveinvestors.com/companies/amp/news/915787

[fidra] 26/5/2020 07:55

Thanks for thre replies,missed it first time where it says they are sent one or other in the pack.

[makendon] 26/5/2020 07:53

Russian article posted this morning



По сло;ваl4; спе;циk2;ли 89;то
074;, в пер;спk7;кт 80;вн
086;й нов;ой тех;ноl3;ог 80;и исп;олn0;зу 77;тс
103; экс;пеl8;им 77;нт
072;льный

According to experts, a promising new technology uses an experimental drug that boosts immunity - SNG001. The composition contains a protein called interferon beta, produced by the body upon infection with a viral infection. Previously, this approach gave good results in the fight against multiple sclerosis, showing a positive trend in alleviating the symptoms of COVID-19 in Hong Kong samples when combined with other medicines. Scientists express the hope that the inhaler will save patients entering the “deadly phase” of the disease, which usually occurs on the tenth day after the onset of the first symptoms. If the trials succeed, Southampton-based Synairgen hopes to release "millions of doses" later this year, which could significantly increase the fight against the pandemic. Research leader Professor Nick Francis said in this regard: “We hope to use an inhaler in the early stages of the disease to prevent the progression of severe symptoms. We can stop people from this bad second week. " As part of a new study, patients will be sent a complete set of test therapy within 72 hours after the development of breathing problems and other symptoms. People will start using the inhaler once a day and record changes in oxygen saturation and temperature. Doctors will check their condition after 14 days to make sure there is no relapse.
Ист;очl5;ик:

[ramridge] 26/5/2020 07:52

This is excellent news.
Not wishing to burst the party balloon, the annual accounts show the need for the company to raise fresh capital. At year end last, they had a cash balance of 2.5m, and the co. 's cash burn was around £4m - £5m during the last FY.
However with the string of good news in sight, they shouldn't have difficulty raising fresh equity at a premium rather than a discount. But they must strike while the iron is hot.

[nobbygnome] 26/5/2020 07:52

Yes definitely placebo controlled!

[best1467] 26/5/2020 07:51

Yes it’s both it does mention briefly

[fidra] 26/5/2020 07:47

Is the home trial also double blind placebo or not,does not make clear.

Or do we assume so since an extension of existing trial.

[faz] 26/5/2020 07:44

"This novel approach is designed to reduce infection risks for both patients and front-line workers" . Am I right to infer the suggestion that the drug will be given as a preventive as well as a treatment?

[d1nga] 26/5/2020 07:43

Data from the hospital initiated (late) patient and home initiated (early) patient populations will be analysed separately as soon as possible, and then together as one population at the end. Top line data from the trial in the hospital setting is expected in July 2020

That's what I wanted to happen the target just improved by a major margin

Game on

[makendon] 26/5/2020 07:42

Opening spread from 55 to 60 ✅